Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin38.7%+2.0pp36.9%+0.4pp36.8%+1.4pp37.7%+2.6pp36.7%+1.4pp
Operating margin14.3%+1.6pp13.1%+4.1pp12.2%+5.2pp13.2%+6.5pp12.7%+6.4pp
Net margin4%+4.5pp2.4%+6.6pp0.2%+7.1pp0.1%+6.8pp-0.5%+6.3pp
Free cash flow margin7.9%-1.0pp8.9%+0.2pp9%-0.9pp9.9%+1.8pp8.9%+1.6pp
Returns
Return on assets3.5%+3.9pp2%+5.4pp0.2%+5.3pp0.1%+4.9pp-0.4%+4.4pp
Return on invested capital20.1%+10.7pp15.7%+5.2pp13.4%+5.9pp10.1%+3.2pp9.4%+3.1pp
Efficiency
Asset turnover0.9×+0.1×0.8×0.0×0.8×+0.1×0.8×+0.1×0.8×+0.1×
Inventory turnover-0.1×3.1×+0.2×3.1×+0.1×0.0×3.1×+0.1×
Liquidity
Current ratio2.5×+1.1×2.2×+0.8×2.1×+0.8×1.4×+0.1×1.4×-0.3×
Quick ratio1.6×+0.7×1.5×+0.6×1.4×+0.6×0.9×+0.1×0.8×-0.1×
Cash ratio0.3×+0.2×0.3×+0.2×0.2×+0.2×0.1×0.0×0.1×0.0×
Leverage
Debt-to-assets0.7×+0.1×0.7×0.0×0.7×0.0×0.6×0.0×0.6×0.0×
Per Share
Book value per share-$0.14+66.0%-$0.22+38.3%-$0.34-11.7%-$0.35-93.0%-$0.41-95.9%
Valuation
Market capitalization$3.97B+51.0%$3.96B+61.4%$3.14B+22.1%$2.55B+30.0%$2.63B+40.4%
Enterprise value$6.34B+33.4%$6.37B+31.7%$5.52B+12.7%$4.65B+7.8%$4.75B+12.2%
Price / earnings32.5×55×532.9×755×
Price / sales1.3×+0.4×1.3×+0.4×1.1×+0.1×0.9×+0.1×0.9×+0.2×
EV / sales2.1×+0.4×2.1×+0.4×1.9×+0.1×1.6×0.0×1.7×0.0×
Free cash flow yield6.1%-3.5pp6.8%-3.1pp8.4%-1.9pp11.1%+0.3pp9.6%-0.2pp
Earnings yield3.1%+3.6pp1.8%+6.6pp0.2%+7.3pp0.1%+9.0pp-0.5%+8.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Amneal Pharmaceuticals, Inc.'s profit margins?
Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.
Where do Amneal Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.